Ken Gordon
Author
Alternate names Kathleen Pieroni Gordon, Ken B. Gordon, K. Gordon, K. B. Gordon, Ken Gordon
Institution Microsoft Research (United Kingdom)
Past institutions Medical College of Wisconsin, Microsoft Research (United Kingdom), Harvard University, Northwestern University, University of Chicago +5 more
H-index: 12
I10-index: 13
Works count: 57
Citations count: 1,587
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial
2005 · Stephen K. Tyring, Alice B. Gottlieb, et al. · The Lancet
Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years
2012 · Alexa B. Kimball, Ken Gordon, et al. · British Journal of Dermatology
Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3
2018 · Kim Papp, Ken Gordon, et al. · British Journal of Dermatology